Jason Pomerantz, MD

Plastic and reconstructive surgeon

Dr. Jason H. Pomerantz is a plastic surgeon who specializes in pediatric plastic and reconstructive surgery including the treatment of craniofacial anomalies. He cares for children and adults with congenital or acquired deformities, especially of the head and face, such as cleft lip and palate, craniosynostosis and traumatic facial injuries.

Pomerantz earned a medical degree at the Albert Einstein College of Medicine in Mew York and completed a residency at UCSF, a postdoctoral research fellowship in regeneration biology at Stanford University and a fellowship in craniofacial surgery at the University of Washington. His research focuses on tissue regeneration and maintenance by stem cells to optimize tissue repair and correct deformities associated with development, trauma or disease. He is an associate professor of surgery in the UCSF School of Medicine.

Clinics

Plastic and Reconstructive (Cosmetic) Surgery
350 Parnassus Ave., Suite 509
San Francisco, CA 94143-0932
Phone: (415) 353-3526
Fax: (415) 353-4330

Hours: Monday to Friday
8 a.m. – 5 p.m.

Plastic and Reconstructive (Non-Cosmetic) Surgery
350 Parnassus Ave., Suite 509
San Francisco, CA 94143-0932
Phone: (415) 353-3526
Fax: (415) 353-4330

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

Board Certification

Plastic Surgery, American Board of Plastic Surgery

Academic Title

Associate Professor

More about Jason Pomerantz

Additional Languages

Spanish

Education

Albert Einstein School of Medicine 2000

Residencies

UCSF Medical Center, Plastic Surgery 2008

Fellowships

Stanford University, School of Medicine, Regeneration Biology 2006
University of Washington Medical Center, Craniofacial Surgery 2009

Selected Research and Publications

  1. Garcia SM, Tamaki S, Lee S, Wong A, Jose A, Dreux J, Kouklis G, Sbitany H, Seth R, Knott PD, Heaton C, Ryan WR, Kim EA, Hansen SL, Hoffman WY, Pomerantz JH. High-Yield Purification, Preservation, and Serial Transplantation of Human Satellite Cells. Stem Cell Reports. 2018 Mar 13; 10(3):1160-1174.
  2. Davies MR, Garcia S, Tamaki S, Liu X, Lee S, Jose A, Pomerantz JH, Feeley BT. Muscle stem cell activation in a mouse model of rotator cuff injury. J Orthop Res. 2017 Aug 08.
  3. Niethamer TK, Larson AR, O'Neill AK, Bershteyn M, Hsiao EC, Klein OD, Pomerantz JH, Bush JO. EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells. Stem Cell Reports. 2017 03 14; 8(3):529-537.
  4. Garcia SM, Tamaki S, Xu X, Pomerantz JH. Human Satellite Cell Isolation and Xenotransplantation. Methods Mol Biol. 2017; 1668:105-123.
  5. Hesse RG, Kouklis GK, Ahituv N, Pomerantz JH. The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration. Elife. 2015 Nov 17; 4.
  6. Xu X, Wilschut KJ, Kouklis G, Tian H, Hesse R, Garland C, Sbitany H, Hansen S, Seth R, Knott PD, Hoffman WY, Pomerantz JH. Human Satellite Cell Transplantation and Regeneration from Diverse Skeletal Muscles. Stem Cell Reports. 2015 Sep 08; 5(3):419-34.
  7. Balkin DM, Chen I, Oberoi S, Pomerantz JH. Bilateral Coronoidectomy by Craniofacial Approach for Hecht Syndrome-Related Trismus. J Craniofac Surg. 2015 Sep; 26(6):1954-6.
  8. Tamaki S, Nye C, Slorach E, Scharp D, Blau HM, Whiteley PE, Pomerantz JH. Simultaneous silencing of multiple RB and p53 pathway members induces cell cycle reentry in intact human pancreatic islets. BMC Biotechnol. 2014 Oct 11; 14:86.
  9. Pomerantz JH, Blau HM. Tumor suppressors: enhancers or suppressors of regeneration? Development. 2013 Jun; 140(12):2502-12.
  10. Garland CB, Pomerantz JH. Regenerative strategies for craniofacial disorders. Front Physiol. 2012; 3:453.
  11. Blau HM, Pomerantz JH. Re"evolutionary" regenerative medicine. JAMA. 2011 Jan 05; 305(1):87-8.
  12. Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, Shkreli M, Delp S, Pomerantz JH, Artandi SE, Blau HM. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell. 2010 Dec 23; 143(7):1059-71.
  13. Pajcini KV, Corbel SY, Sage J, Pomerantz JH, Blau HM. Transient inactivation of Rb and ARF yields regenerative cells from postmitotic mammalian muscle. Cell Stem Cell. 2010 Aug 06; 7(2):198-213.
  14. Pomerantz JH, Mukherjee S, Palermo AT, Blau HM. Reprogramming to a muscle fate by fusion recapitulates differentiation. J Cell Sci. 2009 Apr 01; 122(Pt 7):1045-53.
  15. Palermo A, Doyonnas R, Bhutani N, Pomerantz J, Alkan O, Blau HM. Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. FASEB J. 2009 May; 23(5):1431-40.
  16. Pajcini KV, Pomerantz JH, Alkan O, Doyonnas R, Blau HM. Myoblasts and macrophages share molecular components that contribute to cell-cell fusion. J Cell Biol. 2008 Mar 10; 180(5):1005-19.
  17. Gruber RP, Weintraub J, Pomerantz J. Suture techniques for the nasal tip. Aesthet Surg J. 2008 Jan-Feb; 28(1):92-100.
  18. Wan DC, Pomerantz JH, Brunet LJ, Kim JB, Chou YF, Wu BM, Harland R, Blau HM, Longaker MT. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem. 2007 Sep 07; 282(36):26450-9.
  19. Zhang F, Pomerantz JH, Sen G, Palermo AT, Blau HM. Active tissue-specific DNA demethylation conferred by somatic cell nuclei in stable heterokaryons. Proc Natl Acad Sci U S A. 2007 Mar 13; 104(11):4395-400.
  20. Wehrman TS, Raab WJ, Casipit CL, Doyonnas R, Pomerantz JH, Blau HM. A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions. Proc Natl Acad Sci U S A. 2006 Dec 12; 103(50):19063-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.